MAPPED study design: A 6month randomised controlled study to evaluate the effect of dutasteride on prostate cancer volume using magnetic resonance imaging
Nicola L. Robertson(University College London Hospitals NHS Foundation Trust), Mark Emberton(University College London), Caroline M. Moore(University College London Hospitals NHS Foundation Trust), Brandon Whitcher(Royal Marsden NHS Foundation Trust), Mathias Winkler(National Health Service), Simon Bott(Prostate Cancer Research), Alex Freeman(University College London), Gareth Ambler(University College London), Charles Jameson(Royal London Hospital), A. Kirkham(University College London Hospitals NHS Foundation Trust), Anita Mitra(University College Hospital), Clare Allen(St Peter's Hospital), Giulio Gambarota(Inserm)
Cited by 22
Related Papers
Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study
|The Lancet|2017|3.2k
A Resilient, Low-Frequency, Small-World Human Brain Functional Network with Highly Connected Association Cortical Hubs
|Journal of Neuroscience|2006|2.5k
An Introduction to Wavelets and Other Filtering Methods in Finance and Economics
|Elsevier eBooks|2002|1.1k
The Lancet Commission on prostate cancer: planning for the surge in cases
|The Lancet|2024|694